跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MET-4
首页
药物
MET-4
MET-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
US 8420645 B2
申请人: WENG LINGKAI
优先权: 2008
CN
US
12 件公开
CRYSTAL OF COMPOUND AS C-MET KINASE INHIBITOR AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 3766870 A4
申请人: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
优先权: 2018
CN
EP
US
WO
7 件公开
CRYSTALLINE PSILACETIN DERIVATIVES
EP 4120820 A4
申请人: CAAMTECH INC
优先权: 2020
EP
US
WO
7 件公开
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
US 9266890 B2
申请人: GRAY NATHANAEL S
优先权: 2010
US
6 件公开
COMBINED PHARMACEUTICAL COMPOSITION OF C-MET KINASE INHIBITOR AND ANTI-PD-L1 ANTIBODY
US 2023263795 A1
申请人: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
优先权: 2020
CN
EP
US
WO
5 件公开
PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS
EP 3738964 A1
申请人: DANA FARBER CANCER INST INC
优先权: 2013
EP
US
5 件公开
SALT OF DIOXANE QUINOLINE COMPOUND, CRYSTAL FORM THEREOF, PREPARATION METHODS THEREFOR AND USES THEREOF
EP 4596553 A4
申请人: BEIJING SCITECH MQ PHARMACEUTICALS LTD
优先权: 2022
CN
EP
US
WO
4 件公开
DERIVATIVES OF 2-OXO-N-(4-(PYRIMIDIN-4-YLOXY/THIO)PHENYL)-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE FOR USE AS PROTEIN KINASE INHIBITORS FOR THERAPY
US 2023339889 A1
申请人: AUCENTRA THERAPEUTICS PTY LTD
优先权: 2020
CN
US
WO
3 件公开
Exendin 4 polypeptide fragment
US 2007037747 A1
申请人: CHANGZHOU PHARMACEUTICAL FACTO
优先权: 2005
CN
US
3 件公开
Spirocyclic molecules as protein kinase inhibitors
US 9226923 B2
申请人: WANG ZHAOYIN
优先权: 2012
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈